| Manager | Title | Age | Since |
|---|---|---|---|
Ola Holmlund
CEO | Chief Executive Officer | 57 | 01/01/2018 |
Jan Holmbäck
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/01/2010 |
Charlotta Ekman
DFI | Director of Finance/CFO | 45 | 01/10/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Ola Flink
CHM | Chairman | 82 | 01/01/2017 |
| Chairman | 46 | 01/01/2020 | |
Gunilla Lundmark
BRD | Director/Board Member | 63 | 01/06/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -98.73% | - | - | 92.63K | |
| +2.16% | +3.17% | +43.57% | +160.28% | 1,035B | |
| -0.07% | +4.45% | +53.50% | +48.95% | 574B | |
| -0.08% | -0.08% | +17.37% | +62.66% | 397B | |
| +0.21% | +0.77% | +21.19% | +15.95% | 324B | |
| +0.13% | -1.59% | +23.64% | +15.28% | 281B | |
| +0.35% | +3.46% | +24.46% | +34.37% | 278B | |
| -0.21% | +3.79% | -45.63% | -48.39% | 193B | |
| +4.84% | +2.45% | +21.33% | +61.85% | 191B | |
| +3.61% | -2.56% | +15.16% | +61.12% | 156B | |
| Average | +0.91% | +1.68% | +19.40% | +45.79% | 381.1B | |
| Weighted average by Cap. | +0.57% | +2.39% | +29.35% | +72.87% |
Employees
4
Sector
Pharmaceuticals
